Alessandra Pavesio - 14 Mar 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
Fmr. SVP & Chief Science Off.
Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Issuer symbol
BVS
Transactions as of
14 Mar 2022
Net transactions value
$0
Form type
4
Filing time
21 Apr 2023, 17:05:52 UTC
Previous filing
16 Feb 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +35,545 $0.000000 35,545 14 Mar 2022 Class A Common Stock 35,545 Direct F1, F2
transaction BVS Stock Option (Right to Buy) Award $0 +96,133 $0.000000 96,133 14 Mar 2022 Class A Common Stock 96,133 $1.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs and options, as applicable, shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.